If you’d invested in: Metro Bank and Hikma Pharmaceuticals

If only...

In 2010,Metro Bank (LSE: MTRO) was launched as Britain's first new high-street bank in over 100 years. The firm now has 48 branches or stores as it calls them in the southeast of England.

Metro has had a "superb start to the year", said chairman and founder Vernon Hill, with "improved performance on every level", swinging into profit for the first time. It listed on the London Stock Exchange in March 2016, and in the last year the share price has risen by more than 110%.

Be glad you didn't

Jordan's Hikma Pharmaceuticals (LSE: HIK) makes generic and branded drugs, which it sells primarily in the US, the Middle East and north Africa. Despite a rise in revenue and profits for 2016, its shares fell as part of a wider selloff in generic drugmakers and on news that the US regulator withheld approval for its generic version of asthma drug Advair. The shares are down by more than 40% in the last year.

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up